Nectar Lifesciences (NSE:NECLIFE) Institutional Ownership: 0.05% (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NECLIFE Nectar Lifesciences Ltd NSE:NECLIFE
47 GF Score
Price ₹11.93
GF Value ₹6.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Nectar Lifesciences Institutional Ownership?

Nectar Lifesciences NSE:NECLIFE -0.42% 47 Institutional Ownership is 0.05% as of Sep. 11, 2026. GuruFocus rates NSE:NECLIFE with a GF Score™ of 47/100 and a GF Value™ of ₹6.86 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nectar Lifesciences's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nectar Lifesciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nectar Lifesciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Nectar Lifesciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Nectar Lifesciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nectar Lifesciences Institutional Ownership Chart

Nectar Lifesciences Historical Data

The historical data trend for Nectar Lifesciences can be seen below:

2025-07-31 2025-08-31 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05
NSE:NECLIFE
47GF Score
Nectar Lifesciences Ltd NSE:NECLIFE
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nectar Lifesciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.05% mean?
Nectar Lifesciences (NSE:NECLIFE) has a Institutional Ownership of 0.05% as of Sep. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nectar Lifesciences and its competitors.
Is Nectar Lifesciences' Institutional Ownership too high?
Nectar Lifesciences' current Institutional Ownership is 0.05%. Overall, Nectar Lifesciences has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nectar Lifesciences' Institutional Ownership compare to ZTS?
Nectar Lifesciences' Institutional Ownership of 0.05% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nectar Lifesciences and its competitors. Nectar Lifesciences's current Institutional Ownership is 0.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nectar Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Nectar Lifesciences (NSE:NECLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.86, compared to a current price of ₹11.93 — trading 73.9% above its estimated fair value. The current Institutional Ownership is 0.05%. Nectar Lifesciences' overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Nectar Lifesciences (NSE:NECLIFE), the current Institutional Ownership is 0.05% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nectar Lifesciences (NSE:NECLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Nectar Lifesciences stock appears to be overvalued. The current stock price of ₹11.93 is trading 73.9% above its estimated GF Value™ of ₹6.86. GuruFocus considers Nectar Lifesciences to be Significantly Overvalued.

Key valuation signals for NSE:NECLIFE:

  • Institutional Ownership: 0.05%
  • GF Value™: ₹6.86 vs. price of ₹11.93 (73.9% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the NSE:NECLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nectar Lifesciences Business Description

Other Exchanges 532649:India
Address S.C.O. 38-39, Sector 9-D, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company specializing in Cephalosporins. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products. The Company is also in the Menthol business and succeeded in both domestic and international markets. Its business areas are APIs, Formulations, and Empty Hard Gelatin Capsules. Geographically, it derives a majority of its revenue from India.
47GF Score

Get the complete analysis for NSE:NECLIFE

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.93
Price
₹6.86
GF Value